Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/29/2025

Management of Decompensated Cirrhotic Liver Disease with Portal Hypertension

Initial Assessment and Risk Stratification

  • All patients with decompensated cirrhosis require screening endoscopy to identify esophageal varices, as variceal bleeding represents a life-threatening complication with significant mortality risk 1, 2
  • Assess for clinically significant portal hypertension (CSPH) using liver stiffness measurement and platelet count, as CSPH predicts risk of first decompensation 3
  • Evaluate for ascites, hepatic encephalopathy, and hepatorenal syndrome, which indicate advanced disease requiring aggressive management 1, 2

Medical Management

  • Non-selective beta-blockers (NSBBs) are first-line for primary prophylaxis of variceal hemorrhage, as they reduce portal pressure and prevent multiple complications of portal hypertension 1, 2
  • For patients with medium to large varices, NSBBs are preferred over endoscopic band ligation (EBL) alone for primary prophylaxis 1
  • For secondary prophylaxis (prevention of rebleeding), combined therapy with NSBBs plus EBL is mandatory, as this significantly decreases rebleeding compared to monotherapy 1, 2
  • Immediate administration of vasoactive agents (octreotide) followed by urgent endoscopic therapy is required, as combination therapy improves 5-day hemostasis rates 1, 2
  • Antibiotic prophylaxis must be given to all cirrhotic patients with acute upper gastrointestinal bleeding, as this reduces mortality, bacterial infections, and rebleeding 2

Advanced Interventional Management: TIPS

  • TIPS is strongly indicated for variceal bleeding refractory to endoscopic and drug therapy (failure to control bleeding or early rebleeding despite combined medical and endoscopic treatment) 6, 1, 2
  • Early or pre-emptive TIPS should be performed within 72 hours of variceal bleeding in high-risk patients (Child-Pugh C or MELD ≥19), as this improves survival 6, 1, 2
  • TIPS is recommended for refractory or recurrent ascites in selected patients without contraindications 6, 1, 2
  • Patients should be referred to TIPS expert centers performing ≥10 cases annually, as procedural volume correlates with outcomes 5, 7, 8
  • Covered stents are preferred over bare metal stents due to superior patency rates 2
  • All TIPS procedures in decompensated patients must be discussed with the liver transplant team, as these patients require close coordination between interventional radiology and transplant hepatology 5, 7

Liver Transplantation

  • All patients with decompensated cirrhosis and portal hypertension should undergo liver transplant evaluation, as transplantation is the only curative therapy for end-stage liver disease 4, 3
  • Indications include: recurrent/refractory ascites, refractory variceal bleeding, hepatorenal syndrome, recurrent hepatic encephalopathy, and progressive liver failure 3
  • MELD ≥15 or presence of any decompensation event (ascites, variceal bleeding, encephalopathy, jaundice) warrants transplant referral 5
  • In patients with severe hepatic insufficiency (INR >1.5, abnormal bilirubin, low albumin, refractory ascites or encephalopathy), TIPS may serve as a bridge to transplantation for management of intractable variceal bleeding, but transplantation remains the definitive treatment 4

Critical Pitfalls to Avoid

  • Do not delay transplant evaluation in decompensated patients, as mortality increases rapidly with each decompensation event 5, 4, 3
  • Do not perform TIPS in patients with severe liver insufficiency (Child-Pugh C with MELD >18) unless as a bridge to urgent transplantation, as post-TIPS liver failure carries high mortality 5
  • Do not use TIPS for hepatorenal syndrome outside of clinical trials, as evidence remains insufficient and outcomes are poor 6
  • Ensure multidisciplinary coordination between hepatology, interventional radiology, intensive care, and transplant surgery for optimal outcomes 7, 8